Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Meghmani Organics Earnings Call: Key Takeaways

Meghmani Organics reported FY26 consolidated revenue of ₹2,174 Cr, up 5% YoY, with PAT at ₹28.7 Cr. The company is pivoting towards high-margin Crop Nutrition (Nano Urea) and Titanium Dioxide segments.

Highlights
Revenue growthFY26 Consolidated: 5% YoY; Standalone: 4% YoY.
MarginsFY26 Consolidated EBITDA margin 8.1% vs 6.9% FY25.
Demand visibilitySofter export demand due to macroeconomic uncertainties.
Management confidenceStrong focus on 'China Plus One' strategy and import substitution.

Growth

FY26 Consolidated Revenue grew 5% to ₹2,174 Cr; Standalone PAT rose 89% to ₹125.3 Cr.

Outlook

Commissioning 5,000 MTPA MPP plant for high-value insecticides; expansion in Nano Urea and Titanium Dioxide (TiO2) markets.

Risks

Macroeconomic uncertainties impacting export volumes; rising input costs and stable realisations pressuring margins.

Source

Earnings Call filed with NSE, NSE: MOL. Summary written with AI assistance from the document.

Read the document ↗

Meghmani Organics Ltd: key numbers

Share price
₹58.52
Market cap
₹1,488 Cr
Revenue (annual)
₹2,174 Cr
Net profit (annual)
₹28.74 Cr
P/E (TTM)
23.2×Sector 37.5×
Promoter holding
48.95%+0.00% QoQ
FII holding
0.91%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Meghmani Organics Ltd

All →
18:45 IST BSE
Annual General Meeting

Meghmani Organics Annual General Meeting

Meghmani Organics Limited held its 7th Annual General Meeting on September 8, 2026. The meeting concluded successfully with all items of business transacted as proposed.